EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiological effects of amosulalol a new alpha adrenoceptor and beta adrenoceptor blocker in isolated rabbit papillary muscles


European Journal of Pharmacology 125(3): 411-420
Electrophysiological effects of amosulalol a new alpha adrenoceptor and beta adrenoceptor blocker in isolated rabbit papillary muscles
The electrophysiological effects of amosulalol, a newly developed .alpha.- and .beta.-adrenoceptor blocking agent, were examined and compared with those of labetalol, prazosin and propranolol in isolated rabbit papillary muscles by means of standard microelectrode techniques. Amosulalol above 3 .mu.M produced a concentration-dependent decrease in the maximum rate of depolarization .ovrhdot.Vmax and an increase in action potential duration (APD). Labetalol and prazosin produced a similar APD prolongation, and .ovrhdot.Vmax was depressed by all these drugs in a concentration-dependent manner. The depressant action of these drugs on .ovrhdot.Vmax was enhanced by increasing the stimulation rate from 0.25 to 2.0 Hz. In the presence of these drugs the .ovrhdot.Vmax declined exponentially to a new plateau level (rate-dependent block) and the onset of the rate dependent block for amosulalol at 1 Hz was similar to that for labetalol and propranolol, and faster than that for prazosin. The time constants of the recovery from rate-dependent block for amosulalol, labetalol and prazosin were considerably slower than that for propranolol. These results suggest that amosulalol possesses class I and III antiarrhythmic properties and the recovery from the rate-dependent block of .ovrhdot.Vmax is relatively slow with this drug.


Accession: 005349545



Related references

Electrophysiological effects of amosulalol, a new alpha- and beta-adrenoceptor blocker, in isolated rabbit papillary muscles. European Journal of Pharmacology 125(3): 411-419, 1986

Electrophysiological effects of amosulalol a new alpha beta adrenergic blocker on rabbit papillary muscles. Japanese Journal of Pharmacology 39(SUPPL): 137P, 1985

The time course of the effects of beta adrenoceptor and alpha adrenoceptor stimulation by isoprenaline and methoxamine on the contractile force and cyclic amp level of the isolated rabbit papillary muscle. Naunyn Schmiedeberg's Archives of Pharmacology 289(3): 291-302, 1975

Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol ym 09538 a combined alpha adrenoceptor and beta adrenoceptor blocking agent and the corresponding deoxy derivative ym 11133 in rats. Japanese Journal of Pharmacology 41(4): 459-466, 1986

Electrophysiological effects of alpha-adrenoceptor antagonists in rabbit sino-atrial node, cardiac Purkinje cells and papillary muscles. British Journal of Pharmacology 83(2): 419-426, 1984

Effects of selective alpha 1 adrenoceptor alpha 2 adrenoceptor beta 1 adrenoceptor and beta 2 adrenoceptor stimulation on potentials and contractions in the rabbit heart. Journal of Physiology (Cambridge) 355: 523-546, 1984

Actions of nipradilol k 351 a new alpha adrenoceptor blocker and beta adrenoceptor blocker on the rabbit portal vein. Japanese Journal of Pharmacology 35(4): 359-370, 1984

Metabolism of amosulalol a new alpha beta adrenoceptor blocker in animals and man. Journal of Pharmaceutical Sciences 76(11): S94, 1987

Pharmacokinetics of amosulalol, an alpha, beta-adrenoceptor blocker, in rats, dogs and monkeys. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 14(8): 613-620, 1984

Qualitative differences between the inotropic responses in rat papillary muscles to alpha adrenoceptor and beta adrenoceptor stimulation by both noradrenaline and adrenaline. Acta Pharmacologica et Toxicologica 52(1): 57-67, 1983